Endovascular management of extensive lower extremity acute deep vein thrombosis with AngioJet rheolytic thrombectomy plus catheter-directed thrombolysis from contralateral femoral access. (May 2019)

• Record Type: Journal Article
• Authors: Liu, Guang; Zhao, Zhen; Cui, Chaoyi; Ye, Kaichuang; Yin, Minyi; Liu, Xaiobing; Qin, Jinbao; Huang, Xintian; Lu, Min; Jiang, Mier; Li, Weimin; Lu, Xinwu
• Is Part Of: Phlebology. Volume 34:Number 4(2019)
• Page Start: 257
• Page End: 265
• Publication Date: 2019-05
• Subjects: Catheter-based interventions -- thrombolysis -- venous disease -- VTE management; Veins -- Diseases -- Periodicals; 616.14
• DOI: 10.1177/0268355518790407
• Languages: English
• ISSNs: 0268-3555

Abstract

Purpose: The aim of the present study was to report the clinical outcomes of endovascular treatment for extensive lower limb deep vein thrombosis with AngioJet rheolytic thrombectomy (ART) plus catheter-directed thrombolysis (CDT) using a contralateral femoral approach. Methods: A retrospective analysis of consecutive ART+CDT treatments in 38 deep vein thrombosis patients (LET I-III, from September 2014 to March 2016) was performed. Results: The technical success rate was 100%. Complete lysis was achieved in 82% of LET III segments (calf veins), 87% of LET II segments (popliteal-femoral veins), and 90% of LET III segments (iliac veins). The best results were obtained in patients treated within seven days of symptom onset. During follow-up, well-preserved, competent femoral valves were observed in 86% of the patients, and recanalization of LET III, LET II, and LET I segments was achieved in 100%, 94%, and 91% of the patients, respectively. The post-thrombotic syndrome rate was 17% during a mean 20-month follow-up.